GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pideka Group Inc (OTCPK:CIMVF) » Definitions » ROA %

Pideka Group (Pideka Group) ROA % : -14.30% (As of Sep. 2021)


View and export this data going back to 2021. Start your Free Trial

What is Pideka Group ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Pideka Group's annualized Net Income for the quarter that ended in Sep. 2021 was $-6.12 Mil. Pideka Group's average Total Assets over the quarter that ended in Sep. 2021 was $42.78 Mil. Therefore, Pideka Group's annualized ROA % for the quarter that ended in Sep. 2021 was -14.30%.

The historical rank and industry rank for Pideka Group's ROA % or its related term are showing as below:

CIMVF's ROA % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.54
* Ranked among companies with meaningful ROA % only.

Pideka Group ROA % Historical Data

The historical data trend for Pideka Group's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pideka Group ROA % Chart

Pideka Group Annual Data
Trend
ROA %

Pideka Group Quarterly Data
Mar20 Jun20 Sep20 Mar21 Jun21 Sep21
ROA % Get a 7-Day Free Trial - - -28.13 -89.16 -14.30

Competitive Comparison of Pideka Group's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, Pideka Group's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pideka Group's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pideka Group's ROA % distribution charts can be found below:

* The bar in red indicates where Pideka Group's ROA % falls into.



Pideka Group ROA % Calculation

Pideka Group's annualized ROA % for the fiscal year that ended in . 20 is calculated as:

ROA %=Net Income (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

Pideka Group's annualized ROA % for the quarter that ended in Sep. 2021 is calculated as:

ROA %=Net Income (Q: Sep. 2021 )/( (Total Assets (Q: Jun. 2021 )+Total Assets (Q: Sep. 2021 ))/ count )
=-6.116/( (42.753+42.797)/ 2 )
=-6.116/42.775
=-14.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Sep. 2021) net income data. ROA % is displayed in the 30-year financial page.


Pideka Group  (OTCPK:CIMVF) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Sep. 2021 )
=Net Income/Total Assets
=-6.116/42.775
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-6.116 / 0.252)*(0.252 / 42.775)
=Net Margin %*Asset Turnover
=-2426.98 %*0.0059
=-14.30 %

Note: The Net Income data used here is four times the quarterly (Sep. 2021) net income data. The Revenue data used here is four times the quarterly (Sep. 2021) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Pideka Group ROA % Related Terms

Thank you for viewing the detailed overview of Pideka Group's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pideka Group (Pideka Group) Business Description

Traded in Other Exchanges
N/A
Address
40 King Street West, 2100 Scotia Plaza, Toronto, ON, CAN, M5H 3C2
Pideka Group Inc is multi-national operator with a medical grade indoor cultivation facility and laboratory in Colombia which holds GMP-PHARMA and good agricultural and collection practice certifications, and a retail operation in California.